PMID- 32142998 OWN - NLM STAT- MEDLINE DCOM- 20210226 LR - 20210226 IS - 1878-0334 (Electronic) IS - 1871-4021 (Linking) VI - 14 IP - 3 DP - 2020 May-Jun TI - rs7903146 (C/T) polymorphism of Transcription factor 7 like 2 (TCF7L-2) gene is independently associated with non-alcoholic fatty liver disease in Asian Indians. PG - 175-180 LID - S1871-4021(20)30032-1 [pii] LID - 10.1016/j.dsx.2020.02.011 [doi] AB - BACKGROUND AND AIMS: Transcription factor 7 like 2 (TCF7L-2) polymorphism has been associated with adipocyte metabolism and insulin resistance. Genetic investigations of non-alcoholic fatty liver disease (NAFLD) with obesity, type 2 diabetes mellitus (T2DM) and atherosclerosis are unknown. This study was designed to investigate the association of rs7903146 (C/T) polymorphism of TCF7L-2 gene with non-alcoholic fatty liver disease (NAFLD) in Asian Indians. METHODS: In this case-control study 162 non-diabetic subjects with NAFLD and 173 body mass index (BMI)-matched controls without NAFLD were recruited. Abdominal ultrasound, clinical and biochemical investigations, fasting insulin levels and value of homeostasis model assessment of insulin resistance (HOMA-IR) was measured. Single nucleotide polymorphism rs7903146 (C/T) was genotyped by polymerase chain reaction-restriction fragment length polymorphisms. RESULTS: The distribution of rs7903146 (C/T) alleles, the dominant model (CT + TT) and higher frequency (31%) of C/T genotype were significantly associated with NAFLD. C/T genotype of TCF7L2 gene was associated with significantly higher levels of BMI (p = 0.02), abdominal obesity (p < 0.05), fasting blood glucose (p = 0.05), hepatic transaminases (p < 0.05) and markers of insulin resistance (p < 0.05) in subjects with NAFLD. Using a multivariate analysis after adjusting for age and sex, TCF7L2 polymorphism was independently associated with presence of NAFLD [(OR: 3.234 (95% CI: 1.219-4.160, p = 0.002)]. CONCLUSION: TCF7L2 (C/T) gene was Independently associated with NAFLD in Asian Indians. CI - Copyright (c) 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. FAU - Bhatt, Surya Prakash AU - Bhatt SP AD - Diabetes Foundation (India), Safdarjung Development Area, New Delhi, 110016, India; National Diabetes Obesity and Cholesterol Foundation (N-DOC), Safdarjung Development Area, New Delhi, 110016, India; Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India; Fortis C-DOC Center of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, B-16, Chirag Enclave, New Delhi, India. FAU - Misra, Anoop AU - Misra A AD - Diabetes Foundation (India), Safdarjung Development Area, New Delhi, 110016, India; National Diabetes Obesity and Cholesterol Foundation (N-DOC), Safdarjung Development Area, New Delhi, 110016, India; Fortis C-DOC Center of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, B-16, Chirag Enclave, New Delhi, India. Electronic address: anoopmisra@gmail.com. FAU - Pandey, Ravindra Mohan AU - Pandey RM AD - Biostatics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India. LA - eng PT - Journal Article DEP - 20200221 PL - Netherlands TA - Diabetes Metab Syndr JT - Diabetes & metabolic syndrome JID - 101462250 RN - 0 (Blood Glucose) RN - 0 (Insulin) RN - 0 (TCF7L2 protein, human) RN - 0 (Transcription Factor 7-Like 2 Protein) SB - IM MH - Adult MH - Blood Glucose/analysis MH - Body Mass Index MH - Case-Control Studies MH - Female MH - Humans MH - India/epidemiology MH - Insulin/blood MH - Insulin Resistance/genetics MH - Liver Function Tests MH - Male MH - Middle Aged MH - Non-alcoholic Fatty Liver Disease/*epidemiology/*genetics MH - Obesity, Abdominal/epidemiology/genetics MH - Polymorphism, Genetic MH - Polymorphism, Single Nucleotide/genetics MH - Transcription Factor 7-Like 2 Protein/*genetics OTO - NOTNLM OT - Asian Indians OT - Non-alcoholic fatty liver disease OT - Transcription factor 7 like 2 OT - Type 2 diabetes mellitus COIS- Declaration of competing interest The authors declare that they have no competing interests. EDAT- 2020/03/07 06:00 MHDA- 2021/02/27 06:00 CRDT- 2020/03/07 06:00 PHST- 2020/02/18 00:00 [received] PHST- 2020/02/18 00:00 [revised] PHST- 2020/02/18 00:00 [accepted] PHST- 2020/03/07 06:00 [pubmed] PHST- 2021/02/27 06:00 [medline] PHST- 2020/03/07 06:00 [entrez] AID - S1871-4021(20)30032-1 [pii] AID - 10.1016/j.dsx.2020.02.011 [doi] PST - ppublish SO - Diabetes Metab Syndr. 2020 May-Jun;14(3):175-180. doi: 10.1016/j.dsx.2020.02.011. Epub 2020 Feb 21.